Bayrak EBT (Turkey) Performance
| BAYRK Stock | TRY 17.69 0.42 2.43% |
The firm shows a Beta (market volatility) of -1.18, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Bayrak EBT are expected to decrease by larger amounts. On the other hand, during market turmoil, Bayrak EBT is expected to outperform it. At this point, Bayrak EBT Taban has a negative expected return of -0.024%. Please make sure to confirm Bayrak EBT's value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if Bayrak EBT Taban performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Bayrak EBT Taban has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong forward indicators, Bayrak EBT is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Quick Ratio | 1.00 | |
| Fifty Two Week Low | 7.30 | |
| Fifty Two Week High | 13.75 |
Bayrak |
Bayrak EBT Relative Risk vs. Return Landscape
If you would invest 1,930 in Bayrak EBT Taban on September 2, 2024 and sell it today you would lose (161.00) from holding Bayrak EBT Taban or give up 8.34% of portfolio value over 90 days. Bayrak EBT Taban is generating negative expected returns and assumes 4.7632% volatility on return distribution over the 90 days horizon. Simply put, 42% of stocks are less volatile than Bayrak, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bayrak EBT Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bayrak EBT's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bayrak EBT Taban, and traders can use it to determine the average amount a Bayrak EBT's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.005
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BAYRK |
Estimated Market Risk
| 4.76 actual daily | 42 58% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bayrak EBT is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bayrak EBT by adding Bayrak EBT to a well-diversified portfolio.
Bayrak EBT Fundamentals Growth
Bayrak Stock prices reflect investors' perceptions of the future prospects and financial health of Bayrak EBT, and Bayrak EBT fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bayrak Stock performance.
| Return On Equity | 6.37 | |||
| Return On Asset | 4.72 | |||
| Profit Margin | 6.17 % | |||
| Operating Margin | 11.50 % | |||
| Current Valuation | 227.89 M | |||
| Shares Outstanding | 23.56 M | |||
| Price To Earning | 55.68 X | |||
| Price To Book | 3.29 X | |||
| Price To Sales | 3.32 X | |||
| Revenue | 54.85 M | |||
| EBITDA | 9.21 M | |||
| Cash And Equivalents | 11.2 M | |||
| Cash Per Share | 0.47 X | |||
| Total Debt | 29.16 M | |||
| Debt To Equity | 0.53 % | |||
| Book Value Per Share | 2.35 X | |||
| Cash Flow From Operations | (7.33 M) | |||
| Earnings Per Share | 0.14 X | |||
About Bayrak EBT Performance
By evaluating Bayrak EBT's fundamental ratios, stakeholders can gain valuable insights into Bayrak EBT's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bayrak EBT has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bayrak EBT has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Bayrak Ebt Taban Sanayi Ve Ticaret Anonim Sirketi engages in manufacturing PVC and thermo shoe soles for various brands. BAYRAK TABAN operates under Footwear Accessories classification in Turkey and is traded on Istanbul Stock Exchange. It employs 280 people.Things to note about Bayrak EBT Taban performance evaluation
Checking the ongoing alerts about Bayrak EBT for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bayrak EBT Taban help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bayrak EBT Taban generated a negative expected return over the last 90 days | |
| Bayrak EBT Taban has high historical volatility and very poor performance | |
| Bayrak EBT Taban has accumulated about 11.2 M in cash with (7.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47. | |
| Roughly 45.0% of the company shares are held by company insiders |
- Analyzing Bayrak EBT's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bayrak EBT's stock is overvalued or undervalued compared to its peers.
- Examining Bayrak EBT's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bayrak EBT's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bayrak EBT's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bayrak EBT's stock. These opinions can provide insight into Bayrak EBT's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bayrak Stock analysis
When running Bayrak EBT's price analysis, check to measure Bayrak EBT's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bayrak EBT is operating at the current time. Most of Bayrak EBT's value examination focuses on studying past and present price action to predict the probability of Bayrak EBT's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bayrak EBT's price. Additionally, you may evaluate how the addition of Bayrak EBT to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |